公司資料
Livongo 股價、新聞與催化劑
- 股票代碼:
- LVGO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
目前無法取得 LVGO 的收盤價變動背景。
公司概覽
業務概覽
Livongo was a digital health company focused on chronic disease management, remote monitoring, and data-driven behavior change before being acquired by Teladoc Health. Its core identity was built around applied health signals for diabetes and other chronic conditions.
所在地與產業分類
Livongo was headquartered in the United States and traded on NASDAQ before the merger closed. It sat in digital health rather than therapeutic biotechnology.
商業模式特徵
The company generated value through subscription-style digital health services, data platforms, and chronic-care engagement. Investors historically watched member growth, platform adoption, and the scalability of its virtual care model.
生技產業定位
Livongo was not a biotech company, but it was relevant to the healthcare innovation stack because it influenced chronic-care access and monitoring. Since it was acquired, it now belongs to the historical digital-health category.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。